Events

European Research and Innovation Days 2021
JUN
Wed
23
JUN
Thu
24

This was 4 years ago

Location

virtual

Programmes
Horizon Europe

The European Commission organises the European Research and Innovation Days 2021 edition on 23 and 24 June. Since 2019 this event brings together policymakers, researchers, entrepreneurs and the public to discuss research and innovation in Europe and beyond.

The preliminary programme has been made available on the event website. Any developments in the run up to the event can be found there. In case you would like to receive regular updates in your mailbox you can  subscribe to their newsletter. Updates will be made available also via the Twitter and Facebook account of Directorate-General for Research and Innovation of the European Commission @EUScienceInnov #RiDaysEU. Information on how to participate in the event can be found in the Q&A.

Registration to the event is open from 26 May onwards through this link.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.